COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2021

Sep 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2021-09-16

Reporting Person: Kuhlmann Shirley R. (EVP and General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-16	Common Stock	F	734	$19.67	Disposed	89256	Direct

Footnotes

F1: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.